CID-1067700 (Synonyms: ML282)
目录号: PL10891 纯度: ≥98%
CAS No. :314042-01-8
商品编号 规格 价格 会员价 是否有货 数量
PL10891-5mg 5mg ¥1414.00 请登录
PL10891-10mg 10mg ¥2250.00 请登录
PL10891-25mg 25mg ¥4178.00 请登录
PL10891-50mg 50mg ¥8036.00 请登录
PL10891-100mg 100mg ¥9643.00 请登录
PL10891-200mg 200mg 询价 询价
PL10891-500mg 500mg 询价 询价
PL10891-10mM*1mLinDMSO 10mM*1mLinDMSO ¥1559.00 请登录
Medlife所售产品仅用于科学研究(非临床研究),非药品不可食用,不可用于人体或动物的临床诊断和治疗,我们不为个人提供产品及服务。产品COA等资料,可至下方“质量控制”中下载。
中文名称
CID-1067700
中文别名
2-[[(苯甲酰基氨基)硫代甲酰]氨基]-4,7-二氢-5,5-二甲基-5H-噻吩并[2,3-C]吡喃-3-羧酸;2-(3-苯甲酰硫脲基)5,5-二甲基-5,7-二氢-4H-噻吩[2,3-C]吡喃-3-羧酸;2-(3-苯甲酰硫脲基)5,5-二甲基-5,7-二氢-4H-噻吩[2,3-C]吡喃-3-甲酸;化合物CID-1067700;2-[[(苯甲酰基氨基)硫代甲酰]氨基]-4,7-二氢-5,5-二甲基-5H-噻吩并[2,3-c]吡喃-3-羧酸
英文名称
CID-1067700
英文别名
CID-1067700;2-(Benzoylcarbamothioylamino)-5,5-dimethyl-4,7-dihydrothieno[2,3-c]pyran-3-carboxylic Acid;2-(3-Benzoylthioureido)-5,5-dimethyl-5,7-dihydro-4H-thieno[2,3-c]pyran-3-carboxylic acid;2-[[(Benzoylamino)thioxomethyl]amino]-4,7-dihydro-5,5-dimethyl-5H-thieno[2,3-c]pyran-3-carboxylic acid;CID1067700;CID-1067700,2-(3-benzoylthioureido)-5,5-diMethyl-5,7-dihydro-4H-thieno[2,3-c]pyran-3-carboxylic acid;SID57578339;CS-1986;5H-Thieno[2,3-c]pyran-3-carboxylic acid, 2-[[(benzoylamino)thioxomethyl]amino]-4,7-dihydro-5,5-dimethyl-;ML282,competitively,CID1067700,brain,Rab7,ML 282,GTPase,Ras,machinery,Ras-related,CID-1067700,ML-282,inhibit,CSR,Inhibitor,CID 1067700;2-(Benzoylcarbamothioylamino)-5,5-dimethyl-4,7-dihydrothieno[2,3-c]pyran-3-carboxylic acid
Cas No.
314042-01-8
分子式
C18H18N2O4S2
分子量
390.48
包装储存
Powder -20°C 3 years;4°C 2 years
产品详情
CID-1067700 (ML282) 是 pan GTPase 抑制剂,可竞争性抑制大脑 7 (Rab7) 中的 Ras 相关蛋白,Ki 为 13 nM。
生物活性
CID-1067700 (ML282) is a pan GTPase inhibitor, and competitively inhibits Ras-related in brain 7 (Rab7) with a K i of 13 nM.
性状
Solid
IC50 & Target[1][2]
Ki: 13 nM (Rab7)
体外研究(In Vitro)
CID-1067700 (ML282) is a pan GTPase inhibitor, and competitively inhibits Rab7 with a Ki of 13 nM. CID-1067700 shows inhibitory activity against nucleotide binding by Rab7, with Kds of 100 nM and 40 nM for BODIPY-GTP and BODIPY-GDP, respectively. With increasing concentration, CID-1067700 causes strong inhibition on binding of the BODIPY-linked nucleotides, with EC50 values of 11.22 ± 1.34 nM for BODIPY-GTP and 20.96 ± 1.34 nM for BODIPY-GDP and calculated Ki values of 12.89 nM and 19.70 nM respectively. CID-1067700 (10 μM) has no effect on the rate of release of bound BODIPY-linked nucleotide by wild type Rab7 under equilibrium binding conditions. CID-1067700 (0-40 μM) inhibits Rab7 activity, NF-κB activation as well as AID induction in B cells. Furthermore, CID-1067700 binds Rab7 with a high affinity (EC50: 10-20 nM), an
体内研究(In Vivo)
CID-1067700 (ML282; 16 mg/kg, i.p.) prevents disease development in lupus-prone mice by Rab7 inhibition, and reduces IgG-IC deposition in MRL/Fas mice. CID-1067700 also targets B cells and specifically impairs the CSR machinery in vivo. has not independently confirmed the accuracy of these methods. They are for reference only.
运输条件
Room temperature in continental US; may vary elsewhere.
储存方式
Powder -20°C 3 years;4°C 2 years
参考文献
[1]. Agola JO, et al. A competitive nucleotide binding inhibitor: in vitro characterization of Rab7 GTPase inhibition. ACS Chem Biol. 2012 Jun 15;7(6):1095-108.
[2]. Lam T, et al. Small Molecule Inhibition of Rab7 Impairs B Cell Class Switching and Plasma Cell Survival To Dampen the Autoantibody Response in Murine Lupus. J Immunol. 2016 Nov 15;197(10):3792-3805.
溶解度数据
In Vitro: DMSO : 12.5 mg/mL (32.01 mM; Need ultrasonic)配制储备液
搜索质检报告(COA)

1:一般建议:溶解度为Medlife测试数据,可能与文献描述存在差异。这是由于生产工艺和批次不同产生的正常现象。为了使其更好的溶解,请用37℃加热试管并在超声波水浴中震动片刻。不同批次产品溶解度各有差异,仅做参考,具体以实验方案为准。

2:储存条件:粉末-20°C一般情况可以保存3年,溶于溶剂-80°C一般情况可以保存1年。不同产品及不同批次产品可能存在差异,请细致阅读产品信息,并辅助参考相关文献描述。

The molarity calculator equation
Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)
The dilution calculator equation
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
This equation is commonly abbreviated as: C1V1 = C2V2